BRANDI RHOADS: Open Payments
NPI 1396320461 · TERRE HAUTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$506 in 22 payments from 10 companies in 2025. Trend: 2023 $39 · 2024 $1,042 · 2025 $506
Food & beverage: $506
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 4 | $94 |
| E.R. Squibb & Sons, L.L.C. | 1 | $93 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| Teva Pharmaceuticals USA, Inc. | 4 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $53 |
| Indivior Inc. | 2 | $40 |
| ABBVIE INC. | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Janssen Pharmaceuticals, Inc | 1 | $14 |
| Orexo US, Inc. | 1 | $14 |
Products named: VIVITROL, COBENFY, REXULTI, CAPLYTA, UZEDY, SUBLOCADE, MAVYRET, Auvelity.
Industry payments across IN — which companies pay providers there.
